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uring development, dynamic remodeling of the
actin cytoskeleton allows the precise placement
and morphology of tissues. Morphogens such as
Sonic hedgehog (Shh) and local cues such as receptor
protein tyrosine phosphatases (RPTPs) mediate this pro-
cess, but how they regulate the cytoskeleton is poorly
understood. We previously identiﬁed 
 
Basal cell carci-
noma–enriched gene 4
 
 (
 
BEG4
 
)/
 
Missing in Metastasis
 
(
 
MIM
 
), a Shh-inducible, Wiskott-Aldrich homology 2
domain–containing protein that potentiates Gli transcrip-
tion (Callahan, C.A., T. Ofstad, L. Horng, J.K. Wang,
H.H. Zhen, P.A. Coulombe, and A.E. Oro. 2004.
 
 Genes
D
 
Dev.
 
 18:2724–2729). Here, we show that endogenous
MIM is induced in a 
 
patched1
 
-dependent manner and
regulates the actin cytoskeleton. MIM functions by bun-
dling F-actin, a process that requires self-association but
is independent of G-actin binding. Cytoskeletal remodeling
requires an activation domain distinct from sequences
required for bundling in vitro. This domain associates
with RPTP
 
 
 
 and, in turn, enhances RPTP
 
 
 
 membrane lo-
calization. MIM-dependent cytoskeletal changes can be
inhibited using a soluble RPTP
 
 
 
-D2 domain. Our data
suggest that the hedgehog-responsive gene 
 
MIM
 
 cooper-
ates with RPTP to induce cytoskeletal changes.
 
Introduction
 
The organization of the actin cytoskeleton into higher order
structures is an essential mechanism driving important biological
functions such as changes in cell shape, adhesion, and migration
(Gumbiner, 1992; Bear et al., 2001; Luo, 2002; Dent et al.,
2003). During development, dynamic remodeling of the cyto-
skeleton allows the precise placement and orientation of develop-
ing tissues. Morphogens such as Sonic hedgehog (Shh) are glo-
bal regulators that orchestrate these complex cellular behaviors
to control anterior–posterior, dorsal–ventral, left–right, and
proximal–distal asymmetries in metazoan organs (Meyers and
Martin, 1999; Ruiz i Altaba, 1999; Gurdon and Bourillot,
2001). Increasing numbers of studies have shown that Shh is
capable of directing migration and promoting cellular adhesion,
although how Shh links to the cytoskeleton is unclear (Desh-
pande et al., 2001; Testaz et al., 2001; Charron et al., 2003;
Jarov et al., 2003). Given the diversity of patterning mediated
by Shh even within the same tissue, it is clear that local cues
and signaling pathways are required in addition to Shh to pro-
vide context-specific morphogenetic signals. One prominent
local signaling mechanism is mediated through the receptor
protein tyrosine phosphatases (RPTPs). RPTPs are a large
family of transmembrane proteins that contain a matrix-binding
extracellular domain and a cytoplasmic tyrosine phosphatase
domain (Mustelin et al., 2002; for review see Johnson and Van
Vactor, 2003). RPTPs are believed to use local cues to assem-
ble cytoplasmic signaling complexes that regulate the actin
cytoskeleton, although how this is accomplished is poorly
understood.
Recent work has shed light on how actin cross-linking
proteins contribute to cell shape changes. The initial level of
actin organization occurs through actin-nucleating proteins.
These proteins assemble actin monomers into a fine meshwork
of individual filaments that aid in cell shape changes (Pollard et
al., 2001; Welch and Mullins, 2002). However, in vivo, actin
filaments rarely exist as isolated single filaments, but instead
associate into bundles or networks, in concert with actin–
bundling/cross-linking proteins at key cellular sites. Numerous
studies have documented the wide range in elasticity of fila-
ments with small changes in the concentration of actin-bundling
proteins (Pollard et al., 2000; Gardel et al., 2004). Similar studies
have shown the need for actin-bundling proteins to achieve
mechanical rigidity at the leading edge of migrating cells
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(Xu et al., 1998; Shin et al., 2004). Loss-of-function studies
demonstrate the importance of bundling proteins in processes
such as cell migration, epithelial morphogenesis, and axon
guidance during development (Mahajan-Miklos and Cooley,
1994; Zheng et al., 2000).
Structurally, actin-bundling proteins are modular proteins
that are composed of multiple functional domains (Matsudaira,
1991; Puius et al., 1998; Revenu et al., 2004). Each consists of at
least one F-actin binding domain that facilitates actin cross-link-
ing and whose spacing and orientation determine the quality of
the bundle formed. In addition to the sequences required for ac-
tin cross-linking, each protein also contains “activation” do-
mains distinct from the bundling domain that help regulate the
timing and location of bundle formation within the cell. Exam-
ples include calcium-binding domains that facilitate calcium-
dependent functions (Bretscher and Weber, 1980) and protein
interaction domains that allow association with microtubules or
portions of the plasma membrane (Matsudaira, 1991; Stock et
al., 1999; Tu et al., 2003). The existence of such a modular struc-
ture allows the rapid generation of enormous diversity in the ac-
tin cytoskeleton from a relatively small number of sequences.
In a screen for novel Shh-responsive genes, we have
previously identified 
 
Basal cell carcinoma–enriched gene 4
 
(
 
BEG4
 
)/
 
Missing in Metastasis 
 
(
 
MIM
 
), hereafter called 
 
MIM
 
,
as a Shh-responsive gene in the developing hair follicle and
in basal cell carcinomas of the skin (Callahan et al., 2004).
MIM potentiates Gli-dependent transcription by forming com-
plexes with the Gli transcription factor and the tumor sup-
pressor Suppressor of Fused (Callahan et al., 2004). The
previous identification of MIM binding to monomeric actin
(Mattila et al., 2003; Woodings et al., 2003) suggests that
MIM may be part of a growing family of cytoskeletal regula-
tors that have effects on transcription. To help further under-
stand the role of MIM in morphogenesis, we examined MIM
function in actin cytoskeletal remodeling. Here, we show that
MIM is a Shh-responsive modular protein that remodels the
cytoskeleton by bundling actin filaments. We show that this
activity requires self-association, F-actin binding, and an acti-
vation domain that associates with RPTP
 
  
 
and is required for
localizing it to the membrane. Our data suggest a mechanism
by which MIM facilitates global and local cytoskeletal pat-
terning events.
 
Results
 
Endogenous MIM is induced by hedgehog 
signaling and localizes to actin bundles
 
We have previously identified MIM as a Shh-responsive regu-
lator of Gli transcription (Callahan et al., 2004). To investi-
gate endogenous MIM protein distribution, we developed a
polyclonal antibody to the first 277 amino acids of human
MIM. In myc-tagged MIM-transfected 293 cell lysates, both
the anti-MIM and the epitope antibody recognized the ex-
pected 110-kD band that appears as a doublet, confirming the
antibody specificity (Fig. 1 A). Anti-MIM antisera, but not
preimmune sera, recognized GFP-MIM–expressing cells, and
this immunoreactivity could be blocked with the immunogen
peptide (Fig. S1; available at http://www.jcb.org/cgi/content/
full/jcb.200409078/DC1).
To study MIM expression in a Shh pathway context, we
used 
 
patched (ptch)1
 
 
 
/
 
 
 
 mouse embryonic fibroblasts (MEFs)
in which the pathway is constitutively active (Taipale et al.,
2000). In 
 
ptch1
 
 
 
/
 
 
 
 cells, the anti-MIM antibody recognizes two
major bands, which run at 110 and 100 kD. Consistent with its
role as a Shh-responsive gene, in 
 
ptch
 
 
 
/
 
 
 
 MEFs in which the
Shh pathway is repressed, MIM levels were dramatically re-
duced (Fig. 1 A, right). Similar results are seen in other 
 
ptch1
 
 
 
/
 
 
 
epithelial lines (Koike et al., 2002; unpublished data), support-
ing the idea that loss of 
 
ptch1
 
 up-regulates MIM protein
expression. Shh has been shown to play an important role in
the patterning of the developing neural tube as well as in axon
guidance during development (Charron et al., 2003; Jacob and
Briscoe, 2003; Ruiz i Altaba et al., 2003). Consequently, we at-
tempted to determine whether MIM was expressed in this Shh-
responsive tissue. Indeed, MIM immunoreactivity was detected
in the cytosol of Islet-1–positive, ventral–lateral motor neurons
of the neural tube (Fig. 1 B).
To characterize endogenous MIM subcellular localiza-
tion, we stained 
 
ptch1
 
 
 
/
 
 
 
 fibroblasts with the anti-MIM anti-
body. MIM accumulates on stress fibers and actin-based struc-
tures in the cytoplasm and at the membrane (Fig. 2), but
decorates only a subset of stress fibers, as seen by double stain-
ing with actin (Fig. 2, A–C). In longer cytoplasmic projections,
Figure 1. MIM is a hedgehog-responsive gene. (A) Characterization of
the anti-MIM antibody. (left) Lysates of 293T cells untransfected (C, control)
or transfected with myc-MIM and immunoblotted with an anti-myc mono-
clonal antibody or anti-MIM polyclonal antibody. (right) Lysates from
ptch
 /  and ptch
 /  MEFs immunoblotted with the anti-MIM antibody.
(B) MIM is expressed in a hedgehog-responsive tissue in vivo during spinal
cord development. Paraffin sections of mouse neural tube at day 11.5
stained using the anti-MIM antibody. MIM (green) localizes to the Shh-
responsive ventral part of the neural tube, including motor neurons (Islet-1,
red). (bottom) Magnification of an area showing localization of MIM and
Islet-1 to motor neurons. Nuclei (blue) are labeled with Hoechst staining. 
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MIM decorates the length of the actin bundles but is excluded
from the tips of membrane projections (Fig. 2, D–G). The pres-
ence of numerous short MIM- and actin-containing structures in
peripheral cell areas prompted us to try to determine whether
MIM might colocalize with actin bundles at sites of focal adhe-
sions. Consistent with this idea, double staining with markers of
focal adhesion complexes such as paxillin, FAK, and phospho-
tyrosine epitopes confirmed that MIM is localized subjacent to
focal adhesion complexes (Fig. 2, H–J). Examination of cells
stained with MIM, paxillin, and F-actin demonstrated that MIM
decorates actin bundles (Fig. 2 K) attached to focal adhesions
(Fig. 2 L). From this data, we conclude that MIM is Shh induc-
ible and localizes to actin bundles underlying focal adhesions.
 
Cytoskeletal remodeling by MIM occurs 
through actin bundling
 
The structure and localization of MIM suggest a role in cyto-
skeletal remodeling. Indeed, expression of a GFP-tagged MIM
in C3H10T1/2 cells induces dramatic cytoskeletal abnormali-
ties, including loss of stress fibers, thick actin-rich structures
resembling microspikes, and actin-based cell projections that
are long and thicker than filopodia but narrower than lamelli-
podia (Fig. 3 A and Fig. S2 [available at http://www.jcb.org/
cgi/content/full/jcb.200409078/DC1]). These alterations were
also observed using a myc-tagged MIM in other fibroblast, epi-
thelial, and neural cell lines, but not in cells transfected with
GFP alone (Fig. 3 B; unpublished data), which supports the
specificity of the effect with MIM.
Although the molecular events that generate the actin-
based cell projections are complex, both actin nucleation into
filaments and actin filament bundling have been shown to
contribute to cell morphologic changes in vitro and in vivo
(Pollard et al., 2001; Svitkina et al., 2003; Revenu et al.,
2004). To determine how MIM contributes to actin remodel-
ing, we generated a series of mutants and performed func-
tional analysis in C3H10T1/2 cells (Fig. 3 C). We first focused
on the Wiskott-Aldrich homology 2 (WH2) domain, because it
had been previously implicated in MIM-induced cytoskeletal
changes (Mattila et al., 2003). We confirmed previous results
(Mattila et al., 2003; Woodings et al., 2003) indicating that
MIM binds G-actin with high affinity (
 
K
 
d
 
 
 
 
 
 0.4 
 
 
 
M; Fig. 4
A). Although mutations that substitute (I735A and LK741AH)
or delete (
 
 
 
WH2) conserved residues of the WH2 domain
completely abrogate monomer actin binding (Fig. 4 A, lanes
10–15), the MIM
 
 
 
WH2 mutant, as well as wild-type MIM,
induces cytoskeletal alterations (Fig. 3, D and E). This demon-
strates that the G-actin binding domain is dispensable for the
observed cytoskeletal remodeling. Further evidence comes
from the observation that an NH
 
2
 
-terminal deletion mutant
containing the WH2 domain (MIM
 
 
 
N399) fails to induce a
cytoskeletal phenotype and shows uniform cytoplasmic distri-
bution (Fig. 3, D and E). Our data show that MIM reorganizes
the actin cytoskeleton independently of its G-actin binding
activity and that domains apart from the WH2 are required for
cytoskeletal remodeling.
Because of the dispensability of the WH2 domain in re-
modeling the actin cytoskeleton, we next examined the ability
of MIM to interact with F-actin. F-actin high-speed coprecip-
itation assays using purified GST-MIM demonstrated strong
actin filament binding (Fig. 4 B, lanes 9–12), whereas the
GST and BSA controls showed no significant binding (Fig. 4
B, lanes 1–4 and 17–20). The apparent binding affinity for
F-actin (
 
K
 
d
 
 
 
 
 
 0.15 
 
 
 
M) is similar to that cited in published
reports for other F-actin binding proteins (Martinez-Quiles et
al., 2001). Consistent with the ability to cause a cytoskeletal
phenotype, MIM
 
 
 
WH2 also coprecipitated with F-actin (Fig. 4
B, lanes 13–16).
Actin filament binding of MIM in the absence of the
WH2 domain led us to attempt to determine whether F-actin
bundling, an activity seen in other actin-associated proteins
(Loomis et al., 2003), could explain the cellular phenotype.
Initially, in a low-speed F-actin cosedimentation assay, puri-
fied GST-MIM markedly induced actin filament pelleting
(Fig. 4 C, lanes 3–6) compared with actin filaments alone
(Fig. 4 C, lanes 1 and 2), GST control (Fig. 4 C, lanes 19–22),
or in the presence of MIM mutants (Fig. 4 C, lanes 7–18). Al-
though MIM
 
 
 
WH2 pelleted actin efficiently, MIMN277 and
MIM
 
 
 
N399 displayed markedly reduced bundling activity in
this study. We also found that MIM-dependent actin bundling
was inhibited by phosphoinositol diphosphate (PIP
 
2
 
), a hall-
mark of other actin cross-linking proteins (Stock et al., 1999;
Fig. 4 D). Finally, we directly visualized by transmission
electron microscopy (TEM) the ultrastructure of the actin
Figure 2. Endogenous MIM localizes to actin bundles that support focal
adhesion complexes. Characterization of endogenous MIM localization in
ptch
 /  MEFs. (A–C) In ptch
 /  cells, MIM (A, green) accumulates on a
subset of stress fibers (B, red) near the center of the cell (C, arrow), but
not with more peripheral cortical actin fibers (arrowhead). (D–G) MIM
(D, green) decorates the length of long actin cables (E, red) at sites of
membrane projections. MIM staining continues along actin bundles but is
excluded from the tip of the bundle (note difference in staining near arrow-
heads). (H–J) MIM (green) accumulates on actin bundles that support focal
adhesions complexes. Focal adhesion complexes are marked by staining
with monoclonal antibodies to paxillin (H, blue), FAK (I, blue), and phospho-
tyrosine (J, red). (K–N) Magnified view of 2H showing that MIM (K, green)
decorates the actin bundle (L, red) and is enriched in the area adjacent to
paxillin-labeled focal adhesions (M, blue, and arrowheads in the merged
image N). Bars, 30  m. 
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Figure 3. MIM induces cytoskeletal changes
independently of the WH2 domain. Cytoskeletal
remodeling activity of wild-type and mutant
MIM proteins expressed in C3H10T1/2 cells.
Cells were labeled with an anti-GFP Alexa
Fluor 488 antibody (green) or phalloidin-
TRITC (red, F-actin) and imaged by confocal
microscopy. (A) Full-length GFP-MIM (top) or
GFP (bottom). MIM induces loss of stress fibers,
microspikes (double arrowhead), and actin-
based cell projections (arrowhead). GFP con-
trol does not alter the cytoskeleton, and control-
treated cells have well-defined stress fibers
(arrow). Bar, 30  m. (B) A similar phenotype
is observed when MIM is expressed in the
mouse neuroblastoma cell line Neuro-2a. The
cytoskeleton is dramatically reorganized,
which results in the induction of numerous cell
projections (top, arrowhead), whereas the
GFP control (bottom) has no effect. Bar, 35  m.
(C) Diagram of predicted domains (coil,
coiled-coil; F, F-actin binding; A, activation;
and WH2, WH2 domain) of MIM and the
mutants used in this study. Asterisks repre-
sent the point mutations in the WH2 domain
(*, substitution of I735A; **, substitution
LK741,742AH). (D) The WH2 domain, but
not the NH2 terminus of MIM, is dispensable
for the induction of cell projections. Confocal images of C3H10T1/2 cells transfected with GFP-MIM WH2 (1–724), GFP-MIMN277 (1–277), or GFP-
MIM N399 (400–755). Bar, 30  m. (E) Quantification of the phenotypes observed. Means   SEM (n   3) are shown.
Figure 4. MIM is a novel actin-bundling
protein. (A) The WH2 domain of MIM specifi-
cally binds G-actin. Pull-down assay from a so-
lution of G-actin using different GST-tagged
MIM proteins. Beads (B) and supernatants (S)
were separated by SDS-PAGE and visualized
by antiactin or anti-GST antibodies. MIM
binds to monomeric actin (lanes 2 and 3),
whereas substitution of critical residues (lanes
10–13) or deletion of the WH2 domain (lanes
14 and 15) completely abrogates binding.
(right) Binding data determining the dissocia-
tion constant (Kd   0.4  M) of the interaction
between MIM and monomeric actin. (B) MIM
binds F-actin in vitro. Purified GST-MIM pro-
teins were incubated in the presence ( ) or
absence ( ) of F-actin and cosedimented at
155,000 g. Comparative aliquots of pellet (P)
and supernatant (S) were separated and gels
were stained with Coomassie blue. Both MIM
and MIM WH2 coprecipitate with F-actin
(lanes 9, 10, 13, and 14). (right) Curve to
establish the dissociation constant for the
MIM and F-actin interaction (Kd   0.15  M).
(C) MIM cross-links actin filaments in vitro.
Coprecipitation  assay using purified GST-
MIM proteins and F-actin at 10,000 g. Same
aliquots of pellet (P) and supernatant (S) were
separated by SDS-PAGE and stained with
Coomassie blue. Apparent molecular masses
of used proteins are as follows: MIM, 140 kD;
MIM WH2, 120 kD; MIM N399, 75 kD;
MIMN277, 50 kD; and GST, 27 kD. (D) PIP2
inhibits actin bundling mediated by MIM.
GST-MIM was incubated with ( ) or without
( ) F-actin, in the presence ( ) or absence ( )
of PIP2. Comparable aliquots of pellet (P) and
supernatant (S) were separated by SDS-PAGE
and stained with Coomassie blue. In the ab-
sence of PIP2, F-actin appears mostly in the pellet
fraction (lanes 5 and 6), whereas in the pres-
ence of PIP2, F-actin is shifted to the supernatant
fraction (lanes 7 and 8). (E) Electron micrographs of actin structures in the absence or presence of equimolar amounts of 6XHis-MIM proteins, showing that
MIM and MIM WH2 bundle actin filaments. Bars, 100 nm. 
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bundles induced by MIM (Fig. 4 E). Purified MIM mixed
with actin filaments led to the formation of thick actin bundles.
Similar bundles were seen with MIM
 
 
 
WH2, which shows
that MIM is sufficient to cross-link actin filaments into or-
dered bundles independently of the WH2 domain. Consistent
with the sedimentation assays, MIMN277 and MIM
 
 
 
N399
mutants demonstrated few if any of the bundles seen with
full-length MIM (unpublished data). Our results from these
biochemical and cell biological assays suggest that MIM bun-
dling activity is responsible for the actin-based projections
induced by MIM.
 
The MIM self-association domain is 
required for cytoskeletal remodeling
 
At least two classes of actin cross-linking proteins exist, one
that forms bundles through antiparallel homodimers, such as
 
 
 
-actinin, and another that cross-links directly through multiple
F-actin binding domains on the same molecule (Matsudaira,
1991). The presence of a conserved coiled-coil domain (Fig. 5,
A and B), used by actin cross-linking proteins such as the
plakins (Fontao et al., 2001), suggests that MIM might fit into
the former category. Based on domain analysis programs
(Lupas et al., 1991), the predicted coiled-coil domain lies
Figure 5. MIM NH2-terminal self-association
domain is required for the induction of cyto-
skeletal changes. (A) Diagram of the predicted
coiled-coil region of MIM (http://pbil.ibcp.fr/
html/pbil_index.html). (B) The coiled-coil do-
main is predicted to have distinct hydrophobic
and hydrophilic surfaces. (C) MIM self-asso-
ciates through the NH2-terminal coiled-coil
region.  Pull-down assay from myc-MIM– or
myc-MIMN277–transfected 293T cell lysates
using purified GST-MIM proteins or GST
bound to beads. Proteins were visualized by
Western blot using an anti-myc antibody. MIM
binds to GST-MIMN277 but not the control
GST or MIM N159. (D) Yeast two-hybrid
interaction assay showing single colonies
from cells transformed with indicated bait/
prey plasmids grown on selective media. Full-
length MIM interacts with itself (MIM/MIM) or
the coil domain (MIM/N277), but not with
MIM lacking the coiled-coil domain (MIM/
 N159).   , P53/Large T;  , P53/vector.
MIM/vector, vector/MIM, and vector/N277
demonstrate specificity of the interaction. (E,
left)  Coprecipitation assay of purified GST-
MIM N159 in the presence ( ) or absence
( ) of F-actin to study binding (high speed,
155,000  g) and bundling (low speed,
10,000 g). MIM N159 binds F-actin (lanes 1
and 2) but does not bundle (5 and 6) in vitro.
(right) Electron micrographs of purified F-actin
incubated with MIM N159. This mutant,
which lacks the self-association domain, does
not induce ordered bundles of filamentous
actin.  Bar, 100 nm. (F) Overexpression of
MIM N159 (green) in C3H10T1/2 cells. The
self-association domain is required for the in-
duction of cytoskeletal changes. Note the
presence of stress fibers (F-actin, red) and
minimal cellular projections. Bar, 25  m.JCB • VOLUME 168 • NUMBER 3 • 2005 458
between amino acid residues 100 and 160 and results in a sur-
face of hydrophobic residues opposed by a surface of highly
charged residues (Fig. 5 B). We examined MIM self-association
using GST pull-down assays from lysates of 293T cells trans-
fected with myc-tagged MIM constructs (Fig. 5 C). Indeed, MIM
associated with itself, supporting the homodimer model. The
NH2-terminal fragment MIMN277 was sufficient to bind to full-
length MIM, indicating that it contained the self-association do-
main. Moreover, MIM N159, a mutant lacking the coiled-coil
region, failed to bind to GST-MIMN277 or wild-type MIM (Fig.
5 C). These results were confirmed genetically using a GAL4-
based yeast two-hybrid interaction assay (Fig. 5 D). Cells coex-
pressing a MIM bait plasmid and a prey plasmid containing
either MIM or MIMN277 grew on selective media, whereas cells
expressing MIM plus MIM N159 or vector alone did not grow.
These results confirm and extend previous findings (Yamagishi
et al., 2004) using NH2-terminal peptides and strongly argue for a
specific self-association through the coiled-coil domain.
The importance of MIM self-association was further ex-
amined by testing NH2-terminal mutants in F-actin binding and
bundling assays (Fig. 5 E). If self-association were important
for bundling, then the coiled-coil domain mutant should bind
F-actin but not bundle. Consistent with this idea, MIM N159
bound F-actin in the high-speed coprecipitation assay, but did
not bundle actin in low-speed coprecipitation and TEM analy-
sis (Fig. 5 E). When overexpressed in C3H10T1/2 cells (Fig. 5
F), GFP-MIM N159 distributed uniformly throughout the cy-
tosol and failed to induce stress fiber changes, microspikes, or
cytoplasmic projections (Fig. 6 C). These data demonstrate the
necessity of MIM self-association for both actin cross-linking
and cellular cytoskeletal changes.
The MIM activation domain is required 
for cell projection formation
Studies of other actin-bundling proteins suggest that they are
modular proteins that use activation domains, polypeptides dis-
tinct from those required for actin bundling, to direct cross-
linking to particular subcellular locations (Matsudaira, 1991;
Puius et al., 1998). Our localization of MIM to actin bundles
subjacent to focal adhesions in vivo suggests that membrane
localization plays a role in activating MIM function. In our
MIM structural studies we generated MIMN408, a mutant con-
taining the first 408 amino acids of MIM that is sufficient to
dimerize and bundle in vitro (Fig. 6 A). Surprisingly, this mu-
tant shows a markedly decreased cytoskeletal phenotype with
minimal microspikes, many stress fibers, and fewer cell projec-
tions (Fig. 6, B and C). Subcellular localization of MIMN408
demonstrated that it localized mainly to cytosol, puncta, and
the nucleus. These data point to the existence of a putative acti-
vation domain in MIM required for proper localization/activation
of bundling.
The presence of endogenous MIM in actin bundles sup-
porting focal adhesions in ptch
 /  MEFs suggests that targeting
to these structures may be required for activation. To determine
whether relocalization to lipid-rich areas could restore MIM ac-
tivity, we fused a GAP43 membrane localization domain to
the COOH terminus of MIMN408 (Fig. 6 D). The GAP43 lo-
calization domain from neuromodulin localizes proteins to
cholesterol-enriched focal adhesions at the tips of cytoplas-
mic projections (Laux et al., 2000). Cells transfected with GFP-
MIMN408-GAP43 showed increased staining on the plasma
membrane and dramatically increased cell projections (Fig. 6, C
and D). This mutant also increased ruffle formation, but had only
Figure 6. Characterization of MIM membrane activation. MIMN408 bundles actin in vitro but cannot reconstitute the phenotype of wild-type MIM in
C3H10T1/2 cells. (A, left) Coprecipitation assay of purified GST-MIMN408 in the presence ( ) or absence ( ) of F-actin at high speed (155,000 g) or
low speed (10,000 g) demonstrates both binding (lanes 1 and 2) and bundling (5 and 6). (right) Electron micrograph of MIMN408 incubated with F-actin
by TEM. Bar, 100 nm. (B) Confocal microscopy of C3H10T1/2 cells expressing MIMN408. Cells show increased punctate staining in the cytosol and
fewer cell projections compared with the wild type. Bar, 20  m. (C) Quantification of phenotypes. Means   SEM (n   3) are shown. (D) Addition of a
GAP-43 tag to MIMN408 rescues the cytoskeletal phenotype. Confocal analysis of C3H10T1/2 cells expressing GFP-MIMN408-GAP43 (top, green) or
control YFP-GAP43 (bottom, green). Cells were labeled with an anti-GFP antibody and F-actin (red) was visualized using phalloidin-TRITC. Bar, 25  m.THE SHH-RESPONSIVE GENE MIM IS AN ACTIN-BUNDLING PROTEIN • GONZALEZ-QUEVEDO ET AL. 459
a minimal effect on stress fiber reduction or microspikes, loca-
tions not targeted by the GAP43 tag. This effect was not caused
by GFP overexpression in membrane compartments, as the YFP-
GAP43 control gave no detectable phenotype (Fig. 6, C and D).
These data support the notion that MIM’s presence at lipid-rich
membrane areas is necessary, in addition to self-association and
F-actin binding, for generating membrane projections.
MIM binds to RPTP  and relocalizes it to 
the membrane
To further define the components that activate MIM, we
searched for candidates that associate with the MIM activation
domain. The MIM COOH terminus has previously been shown
to interact with RPTP  (Woodings et al., 2003). Cell and devel-
opmental studies with RPTP  and other Type IIa RPTPs indi-
cate that they assemble a signaling complex at focal adhesions
and are crucial in correctly organizing the cytoskeleton (for re-
view see Johnson and Van Vactor, 2003). Initially, we exam-
ined the significance of tyrosine phosphatase activity for MIM
function. We treated ptch
 /  cells with the phosphatase inhibi-
tor orthovanadate (Heffetz et al., 1990) and examined MIM
localization and activity. Treated cells exhibited a dramatic
reduction in MIM-associated actin cables and cytoplasmic pro-
jections (Fig. 7 A), which is consistent with a role for phos-
phatase activity in MIM function.
To determine whether RPTP  binds to the MIM activa-
tion domain, we performed GST pull-down assays (Fig. 7 B).
Indeed, the RPTP  cytoplasmic domain bound strongly to full-
length MIM but weakly to MIMN408 and not to the GST con-
trol (Fig. 7 B, top). This result is consistent with the reduced
ability of MIMN408 to recapitulate the cell extension pheno-
type observed with full-length MIM. Mutants of the RPTP  cy-
toplasmic tail were used to assess which portion bound to bac-
terially expressed MIM. Truncation mutants of RPTP  lacking
the D2 substrate binding domain did not associate with MIM,
whereas D2 alone did, demonstrating that MIM binds specifi-
cally to the D2 receptor substrate binding region. These results
were reproducible using bacterially expressed RPTP polypep-
tides (Fig. 7 B, bottom). To narrow the activation domain of
MIM, we also tested binding of MIM N399 and MIMN538
mutants to the D2 region. Both of them showed a strong inter-
action with the D2 domain, suggesting that amino acids 400–
538 of MIM contain the RPTP  binding region. This latter
point was further tested by expressing a GST fusion of the
MIM activation domain, which showed a strong binding to the
cytoplasmic domain of RPTP  (Fig. 7 B, top).
We assayed to determine whether the RPTP  D2–MIM
interaction is required for cytoskeletal remodeling. If binding to
the D2 domain at the membrane were required for MIM activity,
then a soluble D2 peptide should prevent RPTP-mediated MIM
membrane activation. In fact, coexpression of soluble D2 with
GFP-MIM inhibited the cell extension phenotype in C3H10T1/2
cells (Fig. 7 C). This inhibition occurred in 70% of the cases. In
these doubly transfected cells, MIM was distributed uniformly
throughout the cytosol, similar to the  N159 or  N399 mutants.
This suggests that interaction with the membrane-associated
RPTP-D2 domain is required for MIM activation.
Although the RPTP –MIM interaction activates MIM-
dependent cytoskeletal remodeling at the membrane, it also ap-
pears to be required for the subcellular localization of RPTP 
to the membrane. Available anti-RPTP  antisera could detect
endogenous expression by Western blot analysis but not by cell
staining, so we examined RPTP distribution using transfected
protein. Staining of expressed RPTP  in the absence of
MIM using a monoclonal anti-RPTP  antibody (Pulido et al.,
1995) revealed a dotlike pattern as well as cytosolic staining in
C3H10T1/2 cells (Fig. 8). In the presence of MIM, the two pro-
teins colocalized and RPTP  distribution was dramatically en-
hanced at the membrane and at sites of cytoplasmic projec-
tions. MIM did not alter the localization of, or colocalize at
Figure 7. MIM cytoskeletal remodeling requires interaction with the
RPTP -D2 domain. (A, left) Phosphatase treatment with orthovanadate
(  vanadate) inhibits endogenous MIM membrane bundles in ptch
 / 
cells but not in cells treated with control (  vehicle). Confocal images of
cells stained for MIM (green) and F-actin (red). Bar, 30  m. (right) Quan-
tification. Means   SEM (n   3) are shown. (B) MIM amino acids 400–538
bind the substrate-binding D2 domain of RPTP . (top) GST pull-down assay
using the indicated GST-MIM beads and cell lysates containing myc-CD
(cytoplasmic domain; apparent molecular mass is 78 kD), myc-D2 (substrate
binding domain 2; runs at 40 kD), or HA-D1 (catalytic domain; runs as a
doublet at 55 kD). AD, MIM activation domain amino acids 401–541.
(bottom) GST pull-down assay using GST-D2 or control GST beads and
the indicated MIM-containing lysates. (C) Coexpression of soluble myc-D2
domain (red) with GFP-MIM (green) blocks cell projections in C3H10T1/2.
Bar, 25  m. Representative cells are shown with anti-GFP (green; top)
and anti-myc (red) staining (bottom).JCB • VOLUME 168 • NUMBER 3 • 2005 460
the membrane with, RPTP - D2, a mutant lacking the D2 do-
main, supporting the in vivo specificity of the interaction with
RPTP . Because of the effects on the subcellular distribution of
MIM in vanadate-treated cells, we attempted to determine
whether the phosphatase activity of RPTP  was required for its
relocalization. RPTP  containing a cysteine-to-serine mutation
in the catalytic domain functioned similarly to the wild-type
protein, suggesting that such activity is not required for MIM-
induced relocalization.
Supporting the importance of the MIM activation domain
in RPTP  localization, MIMN408 did not relocalize nor colo-
calize with RPTP  (Fig. 9). However, MIMN538, a mutant that
also induces a strong cytoskeletal effect (unpublished data),
showed an effect similar to that of full-length MIM (Fig. 9). In
addition, MIM N159, the mutant that failed to self-associate
and bundle (Fig. 5), did not have an effect on RPTP  localiza-
tion (Fig. 9 A, bottom), which is consistent with the idea that
MIM bundling activity is required for enhanced RPTP  mem-
brane localization (Fig. 9 B).
Discussion
Pattern formation during organogenesis requires precise cytoskele-
tal alterations in response to a variety of morphogenic stimuli. Our
data show that the modular Shh effector MIM directly remodels
the actin cytoskeleton by bundling actin. MIM activity is inducible
and can be controlled by regulating expression via Shh signaling
or by modulating activation domain interactions with RPTP .
The data reported here point out a crucial role for the
coiled-coil domain in MIM-dependent bundling activity. In
vitro, the dimerization domain aligns two actin filament binding
domains to allow bundling to occur, just as it does in  -actinin
and other bundling proteins. The biochemical and genetic data
presented in this work with full-length MIM, in conjunction
with previous biochemical data using the MIM NH2 terminus
(Yamagishi et al., 2004), suggest that there is a specific interac-
tion between the MIM dimer and actin filaments, although the
exact stoichiometry, affinity, and orientation of binding of the
protein on the filament will require more careful biophysical
studies. However, the importance of this domain is illustrated by
the observation that having the activation domain without the
coiled-coil domain (MIM N399 or MIM N159) is not suffi-
cient for membrane association, strong bundling, or RPTP relo-
calization. This suggests that in the cell, recognition of MIM by
RPTPs at the membrane requires a three-dimensional surface
provided by the alignment of the dimerization domain. Interest-
ingly, a search of GenBank sequences reveals two other proteins
that have related dimerization sequences, the recently identified
ABBA (Yamagishi et al., 2004) and IRSp53 (Miki et al., 2000;
Nakagawa et al., 2003), which share 90% and 25% identity, re-
Figure 8. MIM alters RPTP  localization and both colocalize on the mem-
brane. Confocal images of C3H10T1/2 cells transfected with the indi-
cated constructs. Cells are labeled with anti-RPTP  antibody and anti-GFP
Alexa Fluor 488. Cells coexpressing RPTP  (red, arrow) and GFP-MIM
(green) show that MIM dramatically enhances RPTP  membrane insertion
compared with cells expressing RPTP alone (arrowhead) and colocalizes
with it (top two rows). (third row) MIM (green) does not colocalize or alter
RPTP - D2 distribution (red, arrowhead). (bottom) The phosphatase activity
of RPTP  is not required for the membrane relocalization as a phos-
phatase-dead mutant (RPTP CS; red, arrowhead) is still inserted at the
plasma membrane when coexpressed with MIM (green). Bars, 5  m.
Figure 9. MIM activation domain is required for RPTP  membrane relo-
calization. (A, top) Coexpression of GFP-MIMN408 (green) with RPTP 
(red). MIMN408 does not colocalize or affect RPTP  distribution (top,
arrowhead). However, GFP-MIMN538, a mutant that contains the activa-
tion domain, does (middle, arrowhead). (bottom) Coexpression of GFP-
MIM N159 (green) with RPTP  (red, arrowhead) shows that the activation
domain is necessary but not sufficient for relocalizing RPTP , and that the bun-
dling activity is also required. Bars, 5  m. (B) Summary of activities of MIM
and MIM mutants on the cytoskeleton and RPTP  binding and localization.THE SHH-RESPONSIVE GENE MIM IS AN ACTIN-BUNDLING PROTEIN • GONZALEZ-QUEVEDO ET AL. 461
spectively. The similarity between MIM and these dimerization
domains suggests that MIM may form heterodimers with other
family members, much like members of the plakin or ezrin/ra-
dixin/moesin subfamilies of cytoskeletal regulators. Preliminary
data suggest that MIM can form heterodimers (unpublished
data) with ABBA, which points to additional diversity in the
ability to generate cytoplasmic projections.
Our data suggest that MIM belongs to a growing family
of cytoskeletal regulators that have transcriptional effects. Pre-
viously reported data indicate that MIM forms a cytoplasmic
complex with Suppressor of Fused and the transcription factor
Gli to regulate transcription (Callahan et al., 2004). This nu-
clear effect is in direct contrast to the cytoplasmic and mem-
brane effects of actin bundling shown here. Because of recent
data suggesting a role for actin binding in transcription (Olave
et al., 2002), we considered the possibility that transcription
was dependent on the MIM bundling domain. However, we ob-
served that MIM potentiates transcription even without the
self-association or WH2 domains that are required for actin
bundling or monomeric actin binding. This supports the idea
that actin bundling and transcriptional potentiation are medi-
ated through distinct domains. Other proteins have been iden-
tified and suggested to regulate the cytoskeleton and tran-
scription, including the Wnt pathway regulators  -catenin and
plakoglobin (Moon et al., 2002; Maeda et al., 2004). Interest-
ingly, the identification of separable domains differs from other
regulators such as  -catenin that use the same domain (arma-
dillo repeats 3–8) to bind to either adherens junctions or to TCF
transcription factors (Rubinfeld et al., 1993; Su et al., 1993;
Hulsken et al., 1994; Sadot et al., 1998).
Another aspect of the modular nature of MIM is the
identification of distinct sequences outside the actin bundling
domain that regulate bundling activity at sites of cytoplasmic
projections. Colocalization studies, together with binding and
cell biological experiments with a blocking polypeptide, sup-
port an important interaction domain between the RPTP D2
domain and MIM amino acids 408–538 (Figs. 7–9). RPTPs
are known to assemble into large complexes of proteins that
regulate the subjacent cytoskeleton during retinal and motor
neuron axon pathfinding (for review see Johnson and Van
Vactor, 2003). Recent data indicate that some associated pro-
teins function to localize RPTPs to focal adhesions and neu-
ronal synapses. For example, liprin binds to the D2 domain
of another type IIa RPTP, LAR, and is required for LAR
function at the synapse, in part by localizing LAR to the syn-
apse (Serra-Pages et al., 1995, 1998; Kaufmann et al., 2002).
Our data suggest a similar function for the activation domain
of MIM on RPTP  to assemble both at the membrane into
specialized membrane domains. Future experiments will ad-
dress whether liprin and MIM are part of the same complex
and direct the RPTPs to similar or different compartments at
the membrane.
The activation domain of MIM greatly enhances MIM
cytoskeletal remodeling in vivo through interaction with
RPTP . Because the cross-linking activity of many bundling
proteins is activated by dephosphorylation (Zhai et al., 2001),
it is tempting to speculate that MIM activity could be con-
trolled via a competition between tyrosine phosphatases and
tyrosine kinases, such as Abl or Src. This is consistent with
the known association of Abl kinase with Type IIa RPTPs
(Wills et al., 1999). Supporting this idea is the strong effect
of phosphatase inhibitors on MIM localization and cytoskele-
tal activity. However, the fact that MIM408-GAP43 rescues
much of the cytoskeletal phenotype by localizing MIM to fo-
cal adhesions (Fig. 6) suggests that RPTP may be playing a lo-
calizing, rather than a catalytic, role with MIM. This is sup-
ported by the ability of MIM to localize a catalytically dead
RPTP to the membrane (Fig. 8) and our observation that the
apparent size of MIM protein does not change in vanadate-
treated cells (unpublished data). Similar results have been
seen with the fly LAR protein, in which catalytically inactive
LAR can rescue LAR-null animals (Krueger et al., 2003). We
speculate that modification of non-RPTP accessory proteins
may be required to activate MIM-dependent actin bundling
activity at the membrane.
Our data provide a framework for how actin bundling
proteins like MIM may coordinate effects of both global and
local signaling pathways on the cytoskeleton during develop-
ment. Morphogens such as Shh induce cytoskeletal regulators
such as MIM and then rely on MIM’s interaction with RPTPs
to localize actin bundles. Interestingly, in the neural tube, MIM
localizes to Shh-dependent and Islet-1–positive motor neurons,
which have been shown to express RPTP  in rats (Sommer et
al., 1997). This suggests that Shh signaling and RPTP may co-
operate to control motor neuron morphogenesis through MIM
during spinal cord development. Future studies to examine how
the activation domain of MIM regulates precise cytoskeletal
changes in vivo will enhance our understanding of how mor-
phogens such as Shh control organogenesis.
Materials and methods
G-actin binding assay
G-actin binding assays were performed using rabbit skeletal muscle actin
(Cytoskeleton, Inc.). Actin at a final concentration of 0.05  M (below the
barbed end concentration) was incubated with 5  g GST-MIM proteins
and 20  l of Sepharose B beads in a final volume of 100  l. Reactions
were performed in a low-salt G-actin buffer (0.2 mM CaCl2, 5 mM Tris-
HCl, pH 8, 0.01% NaN3, and freshly added 0.2 mm ATP and 0.2 mM
DTT). Western blot was performed using a monoclonal skeletal muscle ac-
tin antibody (CHEMICON International). Affinity of MIM for G-actin was
determined using a G-actin binding assay and different amounts of
G-actin. Blots were scanned using the GS-710 (Bio-Rad Laboratories), and
densitometries of the bands were performed using the software Quantity
One (Bio-Rad Laboratories). The dissociation constant was determined us-
ing the GraphPad software. Multiple experiments with different exposures
gave identical affinity results.
F-actin binding coprecipitation assays
High-speed (155,000 g) cosedimentation assays were performed accord-
ing to the manufacturer’s instructions (Cytoskeleton, Inc.). In brief, polymer-
ized actin was incubated with GST-MIM recombinant proteins, BSA, or
 -actinin. Aliquots of pellet and supernatant were run on SDS-PAGE gels
and stained with Coomassie blue. For the F-actin binding curve, we incu-
bated a fixed amount (1  g) of purified GST-MIM with increasing amounts
(0–5  M) of polymerized actin. Fractions of inputs (F-actin added) and
pellets (GST-MIM bound to F-actin) were subjected to SDS-PAGE and blot-
ted with our purified rabbit anti-MIM antibody. Bands were quantified by
densitometry. For low-speed assays, 5  M F-actin (diluted in G buffer from
23- M stock) was subjected to centrifugation for 1 h at RT at 10,000 g.
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spun for 1 h at 10,000 g. Aliquots of pellet and supernatant were run on
SDS-PAGE gels and stained with Coomassie blue.
Electron microscopy
F-actin was polymerized as described in the previous paragraph in poly-
merization buffer at 23  M and further diluted into the same buffer to 1
 M. Filaments were mixed with the recombinant proteins at ratios of 1:60
to 1:240 (actin: 6XHis-MIM proteins) and adsorbed onto glow-discharged
carbon-coated copper grids for 30 s. The grid was washed with two
drops of water before being stained with 1% uranyl acetate for 15 s. Elec-
tron micrographs were taken in a transmission electron microscope (model
JEM-1230; JEOL) at 120 kV.
Antibody generation
Anti-MIM antibodies were generated by injecting purified GST-MIM
amino acids 1–277 into rabbits. On day 224, sera were affinity purified
over a MIM column, generated by covalently attaching purified 6XHIS-
MIM 1–277 with the Amino Link kit (Pierce Chemical Co.).
Immunocytochemistry
C3H10T1/2, Neuro-2a, and PC12 cells were cultured as indicated by
American Type Culture Collection and transfected with FuGENE (Roche).
ptch MEFs were maintained as described previously (Taipale et al., 2000)
and were serum-starved overnight before processing. Neuro-2a cells were
grown on collagen 1–coated chamber slides and in 10% serum. Cells were
fixed and permeabilized in 4% PFA and 1% Triton X-100 before primary
antibody application. For staining of RPTP , cells were fixed for 10 min in
4% PFA, and then washed twice in PBS and permeabilized in 0.5% Triton
X-100. Immunoreactivity was visualized with anti-GFP Alexa Fluor 488 and
Alexa Fluor secondary antibodies (Molecular Bioprobes). Paxillin and FAK
monoclonal antibodies (BD Biosciences), phosphotyrosine monoclonal anti-
body (Cell Signaling), phalloidin-TRITC (Sigma-Aldrich), anti-RPTP  (Pulido
et al., 1995), and monoclonal anti-Myc 9E10 (Sigma-Aldrich) were used
as recommended by the manufacturers. Anti-MIM antibody specificity by
cell staining was tested in C3H10T1/2 cells transfected with GFP-MIM and
immunostained with anti-MIM antibody, preimmune serum or with the anti-
MIM antibody that competed with 600 ng of immunizing peptide, followed
by a secondary goat anti–rabbit Alexa Fluor 546 and Hoechst (Molecular
Bioprobes) staining. For quantitation of loss of stress fibers, induction of mi-
crospikes, or cell projections, cells with projections were defined as either
having three or more dendritic cell projections longer than one cell diame-
ter or having many shorter ones with a filopodium appearance. Statistical
analysis was performed using GraphPad software. Treatment of ptch
 / 
cells with 10  M sodium orthovanadate was performed for 9 h. Cells were
mounted in Vectashield (Vector Laboratories).
Imaging
Cells in Figs. 1–3 and 5–7 were visualized at RT using a confocal laser
scanning system (model MRC 1024; Bio-Rad Laboratories) with a Krypton/
Argon laser. Lens used was 100  oil NA 1.40 Plan Apo (Nikon). Images
were acquired using Lasersharp 2000 and further processed with the Im-
age J software. Neural tube images and Figs. 8 and 9 were collected using
a confocal laser scanning microscope (model LSM 510; Carl Zeiss Micro-
Imaging, Inc.) equipped with a Coherent Mira 900 Tunable Ti:Sapphire la-
ser for two-photon excitation. Lasers used were Argon at 458/488/514
nm, HeNe at 543 nm, and Ti:Sapphire at 780 nm. Objectives used were
Fluor 20  NA 0.75, Plan Apo 63  NA 1.40, and Plan Apo 100  oil
NA 1.40. Images were acquired using the LSM 510 W.S software, version
2.5. All color images were created using Adobe Photoshop 6.0 software.
Neural tube immunofluorescence
Mouse embryos were collected at 11.5 d post coitum, fixed for 7 h in 4%
PFA, and processed for paraffin embedding. Deparaffinized sections
were blocked for 30 min in 10% sheep serum and 0.1% Tween 20, incu-
bated for 2 h in primary antibody, and then incubated for 45 min in sec-
ondary antibody. The antibodies used were rabbit anti-MIM at 1:65 and
mouse anti–Islet-1 at 1:2 (40.2D6; Developmental Studies Hybridoma
Bank). The secondary antibodies used were goat anti–rabbit Alexa Fluor
488 and goat anti–mouse Alexa Fluor 546 at 1:250. The last wash in-
cluded Hoechst at 1:20,000 to stain nuclei.
Online supplemental material
Fig. S1 shows the specificity of the anti-MIM antibody. Fig. S2 more fully
characterizes the MIM-induced cytoskeletal changes in C3H10T1/2 cells.
Additional methods are also included. Online supplemental material is
available at http://www.jcb.org/cgi/content/full/jcb.200409078/DC1.
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